Getting a cancer diagnosis can be overwhelming, especially when you live outside the U.S. and wonder whether your treatment plan is the best possible one. This article explores how MD Anderson Cancer Center’s second opinion service—supported by Medebound HEALTHhelps international patients gain access to world-leading oncology expertise without leaving home

Getting a second opinion at Memorial Sloan Kettering Cancer Center (MSKCC) can provide clarity, confirm diagnoses, and uncover advanced treatment options that may not be available locally. With the support of Medebound HEALTH, international patients can access MSKCC’s world-class cancer specialists through written, video, or on-site consultations—faster, smoother, and with complete translation and concierge support for a truly seamless medical travel experience.

This case study shares the journey of a Chinese patient with astrocytic glioma (WHO Grade 3) who sought advanced treatment guidance through Medebound HEALTH’s international telemedicine platform. By connecting with Professor Patrick, Director of Neuro-Oncology at Harvard’s Dana-Farber Cancer Institute, the family received recommendations for advanced genetic testing, targeted therapies, immunotherapy, and clinical trial opportunities. The consultation provided new hope.